Published in:
01-05-2012 | Invited Editorial
Remote ischemic preconditioning in cardiac surgery: caught between clinical relevance and statistical significance?
Author:
Matthias Thielmann
Published in:
Basic Research in Cardiology
|
Issue 3/2012
Login to get access
Excerpt
Remote ischemic preconditioning (RIPC), which consists of brief episodes of ischemia/reperfusion of remote organs, has been convincingly demonstrated to protect the heart from myocardial infarction [
3,
9,
16,
26]. RIPC also protects other organs such as brain, lung, liver, and kidney [
1,
2,
4,
11,
19,
24,
25]. Recently, RIPC has been brought from the bench to the operating theater. It has been shown in several randomized controlled trials (RCTs) that RIPC attenuates the extent of myocardial injury, as measured by a reduced release of biomarkers reflecting myocardial injury, in various cardiac and vascular surgery scenarios such as abdominal aortic surgery [
1], congenital cardiac surgery [
4], adult heart valve surgery [
14] and coronary artery bypass grafting (CABG) [
7,
10,
22]. …